Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

Talecris Biotherapeutics Holdings Corp. is selling itself too cheaply to Grifols Inc., for $3.4 billion or a $19 share plus 0.641 shares of new, nonvoting Grifols stock for each Talecris share, shareholders claim in Delaware Chancery Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...